OpenScience.ink

1 month ago • Diabetes research and clinical practice

Use of diabetes medicines and weight-loss surgery in U.S. adults with diabetes and obesity over timeTrends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. Adults with diabetes and obesity.

🎖️ Top 10% JournalArticle

1 month ago • Headache

Glucagon-like peptide-1 receptor agonists and their effects in idiopathic intracranial hypertension: A systematic review and meta-analysisGlucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis.

🎖️ Top 10% JournalArticle

1 month ago • Canadian journal of anaesthesia = Journal canadien d'anesthesie

Glucagon-like peptide-1 receptor drugs linked to leftover stomach contents seen during endoscopyGlucagon-like peptide-1 receptor agonists and retained gastric contents on endoscopy: a prospective observational study.

📖 Top 20% JournalArticle

1 month ago • Canadian journal of anaesthesia = Journal canadien d'anesthesie

Fasting and leftover stomach contents before endoscopy in patients taking diabetes drugs called GLP-1 receptor agonistsPreoperative fasting status and retained gastric contents in patients undergoing endoscopy who are using glucagon-like peptide type 1 receptor agonists: a multicentre retrospective study.

📖 Top 20% JournalArticle

1 month ago • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Risk scores for kidney disease, irregular heartbeat, and stroke with new diabetes and heart drugs and high other death risksChronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.

🎖️ Top 10% JournalArticle

1 month ago • Journal of the American Board of Family Medicine : JABFM

New Uses for GLP-1 Agonists Beyond DiabetesNot Just for Diabetes: The Next Frontier for GLP-1 Agonists.

📖 Top 20% JournalArticle

1 month ago • American journal of physiology. Endocrinology and metabolism

A noninvasive breath test to track delayed digestion caused by semaglutide treatment in miceA noninvasive 13C-mannitol breath test to monitor semaglutide treatment-induced delayed oral-cecal transit in mice.

🎖️ Top 10% JournalArticle

1 month ago • Obesity pillars

Building muscle size and strength while losing weight with incretin-based treatmentIncreasing skeletal muscle mass and strength during incretin-based weight loss.

📖 Top 20% JournalArticle

2 weeks ago • Case reports in endocrinology

One-Sided Graves' Disease Appearing During Tirzepatide Treatment in a Person with DiabetesUnilateral Graves' Disease Developing During Treatment With Tirzepatide in a Patient With Diabetes: A Case Report.

Article

yesterday • Journal of cardiothoracic and vascular anesthesia

Guidelines for Treating Heart Failure with Normal Pumping Strength and What They Mean for Heart and Blood Vessel AnesthesiaThe 2026 American College of Cardiology Expert Consensus Decision Pathway for Heart Failure with Preserved Ejection Fraction: Implications for Cardiothoracic and Vascular Anesthesia.

📖 Top 30% JournalArticle

yesterday • Obesity research & clinical practice

How Epigenetic Changes and Diet Together Influence Response to GLP-1Epigenetic determinants of GLP-1 responsiveness: Integrating dietary modulation beyond genetics.

📖 Top 20% JournalArticle

2 days ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

Patient Experiences with Tirzepatide and Dulaglutide for Type 2 Diabetes in the SURPASS-CVOT TrialExit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.

📖 Top 20% JournalArticle

2 days ago • Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition

How a GLP-1 receptor activator may influence food intakeEffect of GLP-1 receptor agonist on nutrient intake: A narrative review.

📖 Top 30% JournalArticle

2 days ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

Heart health outcomes in adults with type 2 diabetes and artery disease starting oral semaglutide versus other non-insulin diabetes medicinesComparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies Among Adults with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

📖 Top 20% JournalArticle

2 days ago • World journal of transplantation

New approaches to weight management after liver transplant using hormone receptor treatmentsRedefining weight management after liver transplantation with glucagon-like peptide one and gastric inhibitory polypeptide receptor agonists.

📖 Top 50% JournalArticle

3 days ago • Mayo Clinic proceedings. Digital health

Body Weight and Blood Pressure Changes After Starting a Glucagon-Like Peptide 1 Drug: Analysis Using Data from Linked DevicesReal-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data.

📖 Top 50% JournalArticle

3 days ago • Clinics in dermatology

The history of diabetes drugs inspired by Gila monster venom and their use in skin treatmentFrom Gila Monster Venom to Dermatology: The History of GLP-1 Receptor Agonists.

📖 Top 50% JournalArticle

4 days ago • Hormones (Athens, Greece)

How receptors help control and treat type 2 diabetesAn illustrative summary of receptor-mediated mechanisms involved in the therapeutic regulation of type 2 diabetes.

📖 Top 30% JournalArticle

4 days ago • Obesity research & clinical practice

Safety and effectiveness of liraglutide for treating obesity in Taiwanese teenagers: a real-world multicenter studyA multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.

📖 Top 20% JournalArticle

6 days ago • Journal of pediatric endocrinology & metabolism : JPEM

Use of GLP-1 receptor drugs and mental health in teenagers with obesity: a look back studyGLP-1 receptor agonist use and mental health outcomes in adolescents with obesity: a retrospective review.

📖 Top 50% JournalArticle

6 days ago • Endocrine journal

Tirzepatide for high blood sugar caused by pasireotide in a hormone-producing pituitary tumor: a case report and reviewTirzepatide for pasireotide-induced hyperglycemia in a GH/TSH-producing pituitary adenoma/PitNET: a case report and literature review.

📖 Top 30% JournalArticle

1 week ago • Clinics in dermatology

GLP-1 Receptor Agonists as Possible Treatments for Skin Conditions Linked to Other DiseasesWhere the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities.

📖 Top 50% JournalArticle

1 week ago • The Knee

Recovery after knee replacement in type 2 diabetes patients treated with semaglutide versus tirzepatidePostoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.

📖 Top 30% JournalArticle

1 week ago • Heart & lung : the journal of critical care

Links between activating glucagon-like peptide-1 receptors, inflammation, and heart failure from genetic studiesGlucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis.

📖 Top 30% JournalArticle

1 week ago • The American journal of cardiology

Factors linked to serious heart problems around the time of weight-loss surgeryPredictors of Perioperative Major Adverse Cardiovascular Events After Bariatric Surgery.

📖 Top 20% JournalArticle

1 week ago • Intestinal research

Comparing tirzepatide and GLP-1 drugs in patients with inflammatory bowel diseaseComparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.

📖 Top 20% JournalArticle

1 week ago • Gastroenterology & hepatology

Use of Glucagon-Like Peptide-1 Receptor Agonists Before and After Liver TransplantGlucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant.

📖 Top 20% JournalArticle

1 week ago • Shoulder & elbow

How drugs that activate GLP-1 receptors may affect recovery after rotator cuff surgeryThe impact of glucagon-like peptide-1 (GLP-1) receptor agonists on postoperative outcomes following rotator cuff repair.

📖 Top 30% JournalArticle

1 week ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

Tirzepatide’s early effects on blood sugar and weight in people with type 2 diabetes in Japan: Study plan and starting dataTirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.

📖 Top 20% JournalArticle

1 week ago • Clinics in dermatology

Ethical issues of prescribing cosmetic GLP-1 drugs in skin careEthical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology.

📖 Top 50% JournalArticle

← prevpage 9 of 14next →

GLP-1 Therapies Research Papers